ZA876411B - A substance or composition comprising 2',3'-dideoxycytidin-2'-ene(2',3'-dideoxy-2',3'-didehydrocytidine)for use in treating patients infected with retroviruses - Google Patents
A substance or composition comprising 2',3'-dideoxycytidin-2'-ene(2',3'-dideoxy-2',3'-didehydrocytidine)for use in treating patients infected with retrovirusesInfo
- Publication number
- ZA876411B ZA876411B ZA876411A ZA876411A ZA876411B ZA 876411 B ZA876411 B ZA 876411B ZA 876411 A ZA876411 A ZA 876411A ZA 876411 A ZA876411 A ZA 876411A ZA 876411 B ZA876411 B ZA 876411B
- Authority
- ZA
- South Africa
- Prior art keywords
- dideoxycytidin
- ene
- didehydrocytidine
- dideoxy
- retroviruses
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US91120086A | 1986-09-24 | 1986-09-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA876411B true ZA876411B (en) | 1988-03-18 |
Family
ID=25429894
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA876411A ZA876411B (en) | 1986-09-24 | 1987-08-27 | A substance or composition comprising 2',3'-dideoxycytidin-2'-ene(2',3'-dideoxy-2',3'-didehydrocytidine)for use in treating patients infected with retroviruses |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP0261595B1 (xx) |
| JP (2) | JPH078796B2 (xx) |
| KR (1) | KR960001372B1 (xx) |
| AT (1) | ATE80039T1 (xx) |
| AU (1) | AU596864B2 (xx) |
| CA (1) | CA1304360C (xx) |
| DE (1) | DE3781488T2 (xx) |
| DK (1) | DK462687A (xx) |
| EG (1) | EG18441A (xx) |
| ES (1) | ES2052533T3 (xx) |
| FI (1) | FI874166A (xx) |
| GR (1) | GR3005870T3 (xx) |
| IE (1) | IE62103B1 (xx) |
| IL (1) | IL83944A (xx) |
| NZ (1) | NZ221893A (xx) |
| PH (1) | PH22990A (xx) |
| PT (1) | PT85755B (xx) |
| ZA (1) | ZA876411B (xx) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5116822A (en) * | 1986-10-24 | 1992-05-26 | Stichting Rega Vzw | Therapeutic application of dideoxycytidinene |
| JPS63107924A (ja) * | 1986-10-25 | 1988-05-12 | Yamasa Shoyu Co Ltd | 抗レトロウイルス剤 |
| US5631370A (en) * | 1988-01-20 | 1997-05-20 | Regents Of The University Of Minnesota | Optically-active isomers of dideoxycarbocyclic nucleosides |
| US5175292A (en) * | 1988-01-20 | 1992-12-29 | Regents Of The University Of Minnesota | Intermediates for the preparation of dideoxycarbocyclic nucleosides |
| JPH02152976A (ja) * | 1988-05-06 | 1990-06-12 | Bristol Myers Co | ２´，３´―ジデヒドロ―２´，３´―ジデオキシヌクレオシドのプロドラッグ |
| SE8802687D0 (sv) * | 1988-07-20 | 1988-07-20 | Astra Ab | Nucleoside derivatives |
| EP0355031A3 (de) * | 1988-08-17 | 1990-12-27 | MATTHES, Eckart, Dr. | Substituierte Pyrimidinnucleoside, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Mittel |
| FI95269C (fi) * | 1989-05-15 | 1996-01-10 | Squibb Bristol Myers Co | 2',3'-dideoksi-inosiinimonohydraatin, 2',3'-dideoksi-2',3'-didehydrot ymidiinimonohydraatin ja 2',3'-dideoksi-2'-fluori-inosiinihemihydraatin antiviraalisia, hyvin vesiliukoisia, stabiileja, kiteisiä suoloja |
| US5629016A (en) * | 1991-01-30 | 1997-05-13 | Glaxo Wellcome Inc. | Water-dispersible tablets |
| NL9220009A (nl) * | 1991-01-30 | 1993-11-01 | Wellcome Found | In water-dispergeerbare tabletten. |
| GB9215908D0 (en) * | 1992-07-27 | 1992-09-09 | Wellcome Found | Water dispersible tablets |
| US5698226A (en) * | 1993-07-13 | 1997-12-16 | Glaxo Wellcome Inc. | Water-dispersible tablets |
| ATE284894T1 (de) * | 1994-10-24 | 2005-01-15 | Genencor Int | L-pyranosyl-nukleoside |
| US5559101A (en) * | 1994-10-24 | 1996-09-24 | Genencor International, Inc. | L-ribofuranosyl nucleosides |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3817982A (en) * | 1971-12-29 | 1974-06-18 | Syntex Inc | 2{40 ,3{40 -unsaturated nucleosides and method of making |
| FR2528311B1 (fr) * | 1982-06-14 | 1985-06-14 | Synthelabo | Compositions pharmaceutiques a base de xylosides et lyxosides de bases puriques et pyrimidiques |
| JPS62501777A (ja) * | 1985-08-26 | 1987-07-16 | アメリカ合衆国 | ２′，３′―ジデオキシシチジンを含有する抗ｈｔｌｖ―３／ｌａｖ剤 |
| WO1987004929A1 (en) * | 1986-02-20 | 1987-08-27 | Greer Sheldon B | Composition for and method of treating aids and certain related diseases |
-
1987
- 1987-08-24 KR KR1019870009248A patent/KR960001372B1/ko not_active IP Right Cessation
- 1987-08-27 EG EG506/87A patent/EG18441A/xx active
- 1987-08-27 ZA ZA876411A patent/ZA876411B/xx unknown
- 1987-09-01 PH PH35756A patent/PH22990A/en unknown
- 1987-09-02 JP JP62218077A patent/JPH078796B2/ja not_active Expired - Lifetime
- 1987-09-04 DK DK462687A patent/DK462687A/da not_active Application Discontinuation
- 1987-09-04 AU AU77977/87A patent/AU596864B2/en not_active Ceased
- 1987-09-17 AT AT87113638T patent/ATE80039T1/de not_active IP Right Cessation
- 1987-09-17 EP EP87113638A patent/EP0261595B1/en not_active Expired - Lifetime
- 1987-09-17 ES ES87113638T patent/ES2052533T3/es not_active Expired - Lifetime
- 1987-09-17 DE DE8787113638T patent/DE3781488T2/de not_active Expired - Fee Related
- 1987-09-18 IL IL83944A patent/IL83944A/xx unknown
- 1987-09-18 PT PT85755A patent/PT85755B/pt not_active IP Right Cessation
- 1987-09-22 NZ NZ221893A patent/NZ221893A/en unknown
- 1987-09-23 FI FI874166A patent/FI874166A/fi not_active Application Discontinuation
- 1987-09-23 CA CA000547640A patent/CA1304360C/en not_active Expired - Lifetime
- 1987-09-23 IE IE256287A patent/IE62103B1/en not_active IP Right Cessation
-
1992
- 1992-10-01 GR GR920402202T patent/GR3005870T3/el unknown
-
1994
- 1994-07-27 JP JP6193823A patent/JPH0818986B2/ja not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| CA1304360C (en) | 1992-06-30 |
| EG18441A (en) | 1992-12-30 |
| DK462687A (da) | 1988-03-25 |
| PT85755B (pt) | 1990-08-31 |
| IE872562L (en) | 1988-03-24 |
| GR3005870T3 (xx) | 1993-06-07 |
| JPH07145058A (ja) | 1995-06-06 |
| FI874166A0 (fi) | 1987-09-23 |
| EP0261595A2 (en) | 1988-03-30 |
| IL83944A (en) | 1993-01-31 |
| AU7797787A (en) | 1988-03-31 |
| DE3781488D1 (de) | 1992-10-08 |
| JPH078796B2 (ja) | 1995-02-01 |
| FI874166A (fi) | 1988-03-25 |
| AU596864B2 (en) | 1990-05-17 |
| KR880003626A (ko) | 1988-05-28 |
| PH22990A (en) | 1989-02-24 |
| DK462687D0 (da) | 1987-09-04 |
| EP0261595A3 (en) | 1990-01-24 |
| IE62103B1 (en) | 1994-12-14 |
| JPH0818986B2 (ja) | 1996-02-28 |
| EP0261595B1 (en) | 1992-09-02 |
| IL83944A0 (en) | 1988-02-29 |
| ES2052533T3 (es) | 1994-07-16 |
| PT85755A (en) | 1987-10-01 |
| DE3781488T2 (de) | 1993-02-18 |
| ATE80039T1 (de) | 1992-09-15 |
| JPS63146822A (ja) | 1988-06-18 |
| KR960001372B1 (ko) | 1996-01-26 |
| NZ221893A (en) | 1990-11-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA877171B (en) | A substance or composition comprising 3'-deoxythymidin-2'-ene(3'-deoxy-2',3'-didehydrothymidine)for use in treating patients infected with retroviruses | |
| ZA876411B (en) | A substance or composition comprising 2',3'-dideoxycytidin-2'-ene(2',3'-dideoxy-2',3'-didehydrocytidine)for use in treating patients infected with retroviruses | |
| DK275488D0 (da) | Indolonderivater | |
| GR3019388T3 (en) | The use of buspirone for preparing a pharmaceutical composition for the treatment of alcohol abuse | |
| IL84844A0 (en) | Pharmaceutical compositions comprising a certain carbazolone derivative or a salt thereof | |
| ATE141796T1 (de) | 2',5'-oligoadenylat-derivate zur verwendung als heilmittel | |
| AU2234588A (en) | Administration of extremely low dosages of dideoxynucleoside analogs for treating or preventing AIDS in subjects |